About
Rogier Rooswinkel is a General Partner at Forbion's Naarden office, which he joined in 2013, where he evaluates and structures new investment opportunities across disease areas with a focus on oncology. Before Forbion, he was a post-doctoral researcher at the Netherlands Cancer Institute (NKI) in the division of immunology, and during his studies he worked as an independent website designer and founded an IT company. He earned a PhD Cum Laude from the University of Amsterdam in 2013 for work at the NKI, and holds a Master's degree in Oncology from VU University Amsterdam.
Invests in
Biotech
Experience
- Forbion - Impacting the future of medicineGeneral Partnercurrent2013 — presentNaarden
- Netherlands Cancer InstitutePostdoc2013Amsterdam
- Netherlands Cancer InstitutePhD-student2008 — 2013Amsterdam
- KlachtenCentraleOwner2005 — 2007Amsterdam
- VU medical CentreTechnician and programmer2003 — 2007
Investments
Board seats
AchillesAmphistaCatalymGraniteLoqus23PheonTessellate
Investor
EnterpriseKaNDyReplimuneRigontec
Per the firm's website.
Colleagues at Forbion
Alexander Hoffmann
General Partner at Forbion
Alice Vickers
Advisor at Forbion
Antoine Boulanger Piette
Principal at Forbion
Audrey Cacaly
Principal at Forbion
Carlo Incerti
Operating Partner at Forbion
Dirk Kersten
Managing Partner at Forbion
Dmitrij Hristodorov
General Partner at Forbion
Geert-Jan Mulder
Managing Partner at Forbion
Frequently asked questions
- Who is Rogier Rooswinkel?
- Rogier Rooswinkel is a General Partner at Forbion's Naarden office, which he joined in 2013, where he evaluates and structures new investment opportunities across disease areas with a focus on oncology. Before Forbion, he was a post-doctoral researcher at the Netherlands Cancer Institute (NKI) in the division of immunology, and during his studies he worked as an independent website designer and founded an IT company. He earned a PhD Cum Laude from the University of Amsterdam in 2013 for work at the NKI, and holds a Master's degree in Oncology from VU University Amsterdam.
- Where does Rogier Rooswinkel work?
- Rogier Rooswinkel is General Partner at Forbion.
- What does Rogier Rooswinkel invest in?
- Rogier Rooswinkel invests in Biotech.
- What boards does Rogier Rooswinkel sit on?
- Rogier Rooswinkel holds tracked board seats at Achilles, Amphista, Catalym, Granite, Loqus23, Pheon, Tessellate.
- What companies has Rogier Rooswinkel invested in?
- Investments tracked here include Enterprise, KaNDy, Replimune, Rigontec.
- Where did Rogier Rooswinkel go to school?
- Rogier Rooswinkel studied at Netherlands Cancer Institute (PhD (cum laude)); Vrije Universiteit Amsterdam (VU Amsterdam) (MSc, Oncology); Vrije Universiteit Amsterdam (VU Amsterdam) (BSc, Medical Natural Sciences).
Same school
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)149
Brendan Bulik-SullivanInvestor at GV (Google Ventures)Kyang YungInvestor at DaphniJohann FriederichAssociate at Notion CapitalTies KlinkhamerJunior Associate at Keen Venture PartnersMercedes TuinPartner at Heran PartnersProf. Dr. Jan Peter BalkenendeVoorzitter at Noaber
+ 143 more
Shared employers
Also worked at Forbion - Impacting the future of medicine23
Christina TakkeManaging Partner at V-Bio VenturesMathias FalcenbergVenture Partner at V-Bio VenturesIvan BurkovJunior Partner at InkefAnne Marije van HartenInvestment Director at Apollo Health VenturesAntoine BoulangerPartner at Apollo Health VenturesRobbert van de GriendtHead of Investment Relations at BioGeneration Ventures
+ 17 more
Also worked at Netherlands Cancer Institute2
Also worked at VU medical Centre16
René KuijtenInvestor at LSP (Life Sciences Partners)René R. KuijtenInvestor at LSP (Life Sciences Partners)Mercedes TuinPartner at Heran PartnersTherese LiechtensteinPartner at 4BIO CapitalMercedes TuinInvestment Director at BOMRené KuijtenPartner, Head of EQT Life Sciences at EQT Life Sciences
+ 10 more